Jeffrey A. Lieberman

96.6k total citations · 19 hit papers
602 papers, 54.1k citations indexed

About

Jeffrey A. Lieberman is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Jeffrey A. Lieberman has authored 602 papers receiving a total of 54.1k indexed citations (citations by other indexed papers that have themselves been cited), including 365 papers in Psychiatry and Mental health, 116 papers in Cellular and Molecular Neuroscience and 100 papers in Cognitive Neuroscience. Recurrent topics in Jeffrey A. Lieberman's work include Schizophrenia research and treatment (342 papers), Bipolar Disorder and Treatment (89 papers) and Mental Health and Psychiatry (73 papers). Jeffrey A. Lieberman is often cited by papers focused on Schizophrenia research and treatment (342 papers), Bipolar Disorder and Treatment (89 papers) and Mental Health and Psychiatry (73 papers). Jeffrey A. Lieberman collaborates with scholars based in United States, Canada and Germany. Jeffrey A. Lieberman's co-authors include Joseph P. McEvoy, T. Scott Stroup, Diana O. Perkins, Sonia M. Davis, Robert A. Rosenheck, Richard S.E. Keefe, Marvin S. Swartz, John Hsiao, John M. Kane and Robert M. Bilder and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Jeffrey A. Lieberman

591 papers receiving 51.7k citations

Hit Papers

Effectiveness of Antipsychotic Drugs in Patients with... 1992 2026 2003 2014 2005 1999 2005 2005 2006 1000 2.0k 3.0k 4.0k

Peers

Jeffrey A. Lieberman
Comparison fields: 5 of 200
  • Psychiatry and Mental health 34.0k
  • Cognitive Neuroscience 9.1k
  • Clinical Psychology 8.8k
  • Cellular and Molecular Neuroscience 8.6k
  • Philosophy 7.1k
John M. Kane United States
Ming T. Tsuang United States
Nancy C. Andreasen United States
Philip McGuire United Kingdom
Jim van Os Netherlands
René S. Kahn Netherlands
Matcheri S. Keshavan United States
Herbert Y. Meltzer United States
Shitij Kapur Canada
Richard S.E. Keefe United States
John M. Kane United States View profile →
Citations per field, relative to Jeffrey A. Lieberman
Jeffrey A. Lieberman · 1×
Citations per year, relative to Jeffrey A. Lieberman
Jeffrey A. Lieberman · 1×

Countries citing papers authored by Jeffrey A. Lieberman

Since Specialization
Citations

This map shows the geographic impact of Jeffrey A. Lieberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey A. Lieberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey A. Lieberman more than expected).

Fields of papers citing papers by Jeffrey A. Lieberman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey A. Lieberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey A. Lieberman. The network helps show where Jeffrey A. Lieberman may publish in the future.

Co-authorship network of co-authors of Jeffrey A. Lieberman

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey A. Lieberman. A scholar is included among the top collaborators of Jeffrey A. Lieberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey A. Lieberman. Jeffrey A. Lieberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 The neurobiology of duration of untreated psychosis: a comprehensive review Molecular Psychiatry Anthony W. Zoghbi, Jeffrey A. Lieberman et al. 18
2 High-impact rare genetic variants in severe schizophrenia Proceedings of the National Academy of Sciences Anthony W. Zoghbi, Ryan S. Dhindsa et al. 33
3 Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers Neuropsychopharmacology Joshua T. Kantrowitz, Jack Grinband et al. 35
4 Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine The Pharmacogenomics Journal François Girardin, Antoine Poncet et al. 29
5 Pharmacological Treatments for Schizophrenia Oxford University Press eBooks Atheir I. Abbas, Jeffrey A. Lieberman 4
6 Anatomical Abnormalities in Gray and White Matter of the Cortical Surface in Persons with Schizophrenia PLoS ONE Tiziano Colibazzi, Bruce E. Wexler et al. 20
7 Association study of GRIK1 gene polymorphisms in schizophrenia: case–control and family‐based studies Human Psychopharmacology Clinical and Experimental Yuko Hirata, Clement C. Zai et al. 14
8 Proof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia Neuropsychopharmacology Brian P. Marx, Richard S.E. Keefe et al. 160
9 Presynaptic Regulation of Dopamine Transmission in Schizophrenia Schizophrenia Bulletin Gholson J. Lyon, Anissa Abi‐Dargham et al. 51
10 Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of olanzapine versus haloperidol (American Journal of Psychiatry (2003) 160, (1396-1404)) American Journal of Psychiatry Jeffrey A. Lieberman, G.D. Tollefson et al. 12
11 Science and Recovery in Schizophrenia Psychiatric Services Jeffrey A. Lieberman, Robert E. Drake et al. 112
12 The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia Neuroscience Letters Daniel J. Müller, Tim Klempan et al. 77
13 Antipsychotic-Induced Weight Gain and Therapeutic Response: A Differential Association Journal of Clinical Psychopharmacology Pál Czobor, Jan Volavka et al. 147
14 Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle. PubMed Vincenzo S. Basile, Mario Masellis et al. 170
15 Comprehensive care of schizophrenia : a textbook of clinical management Jeffrey A. Lieberman, Robin Murray 32
16 Novel histamine H1 gene polymorphism and clozapine-induced weight gain American Journal of Medical Genetics Part B Neuropsychiatric Genetics Vincenzo S. Basile, Mario Masellis et al. 2
17 Psychiatry : behavioral science and clinical essentials Jerald Kay, Allan Tasman et al. 3
18 Ethics in psychiatric research : a resource manual for human subjects protection DigitalGeorgetown (Georgetown University Library) Harold Alan Pincus, Jeffrey A. Lieberman et al. 32
19 Pocket companion to accompany psychiatry Allan Tasman, Jeffrey A. Lieberman et al. 1
20 The moral imperatives of medical research in human subjects. PubMed Jeffrey A. Lieberman et al. 2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026